Etiqueta: doses
Abdala, with three doses, demonstrates 92.28% efficacy
Abdala- A three-dose regimen of the Abdala candidate vaccine has demonstrated an efficacy of 92.28 percent, placing it well above the World Health Organization (WHO) requirement of at least 50 percent, to be recognized as an anti-COVID-19 vaccine.
Cuba scales up industrial production of candidate vaccines
Cuba- Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities
Abdala, a partir de hoy en II Fase de Ensayo Clínico en Santiago de Cuba
Abdala- Por: Betty Beatón Ruíz. A partir de hoy en Santiago de Cuba, segunda Fase de Ensayo Clínico vacunal Abdala contra la covid-19. Ciencia y Conciencia.
Prevén ensayos con candidatos vacunales contra COVID-19 en pacientes pediátricos para finales de febrero
Ensayos. El ensayo con los candidatos vacunales Soberana 01 y Soberana 02 en pacientes pediátricos se prevé para finales de febrero,
Cuba readies 100 million doses of anti-COVID vaccine
Finlay Vaccine Institute director, Dr. Vicente Vérez Bencomo, reports that Cuba is creating capacity to produce 100 million doses of the Soberana 02 vaccine
